admin – Page 2 – Greenrise Global

AMP Announces Non-Brokered Placement to Raise Growth Capital

Post author:admin
Post published:October 1, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT and BERLIN, Germany – October 1st, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX) (“AMP”), a pharmaceutical supplier of medical and CBD therapeutic wellness cannabis…

AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

Post author:admin
Post published:September 28, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT and BERLIN, Germany – September 28th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX) (“AMP”), a pharmaceutical supplier of medical and CBD therapeutic wellness cannabis…

AMP and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

Post author:admin
Post published:September 13, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT / BERLIN and STADTBERGEN, Germany – September 13th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German…

AMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany’s Largest Cancer Convention

Post author:admin
Post published:September 8, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT / BERLIN, Germany – September 8th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of cosmetic CBD cannabis products to German pharmacies,…

AMP Launches HANAFSAN Branded CBD Cannabis Cosmetics Products in Germany

Post author:admin
Post published:May 12, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT / BERLIN, Germany, and VORARLBERG, Austria – May 12, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to…

AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany

Post author:admin
Post published:April 7, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT and BERLIN, Germany, April 7th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment…

AMP Announces Stock Option Grant

Post author:admin
Post published:April 5, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT and BERLIN, Germany, April 5th, 2021 – AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces that…

AMP Alternative Medical Products Closes Oversubscribed Non-Brokered Private Placement

Post author:admin
Post published:February 10, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT and BERLIN, Germany, February 10th, 2021, AMP Alternative Medical Products Inc. (Formerly AMP German Cannabis Group Inc.) (“AMP”) (CSE: XCX), (Frankfurt: C4TA, ISIN: CA0318961038), a licenced importer of medical…

AMP German Cannabis Group Changes Company Name to AMP Alternative Medical Products

Post author:admin
Post published:January 29, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT / BERLIN, Germany, January 29th, 2021 – AMP German Cannabis Group Inc. (“AMP” and or “the Company”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has changed its…

AMP German Cannabis Group and Aphria’s subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

Post author:admin
Post published:January 26, 2021
Post category:News Releases Uncategorized
Post comments:0 Comments

ERFURT / BERLIN / DENSBORN, Germany, and LEAMINGTON, Ontario, Canada – January 26th, 2021– AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) and Aphria Inc.’s (“Aphria”)…

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.